Capgemini's decision is set against a backdrop of slowing activity in France and an acceleration of technological changes. The rise of artificial intelligence is among the key factors driving the ...

EssilorLuxottica shares have fallen 4.42% to 289.80 euros at midday on December 9, with trading volumes representing 0.04% of the capital. This decline, following a previous close at 303.20 euros, ...

Recent analyst publications indicate increased caution regarding the stock. Deutsche Bank lowered its price target from 30 euros to 27 euros on January 21, while maintaining a neutral 'hold' ...

The French energy company has reached a symbolic milestone that reflects the growing enthusiasm of investors for its prospects. Analyst confidence has recently strengthened with two notable ...

Aperam organizes its activities around four interconnected segments: Stainless & Electrical Steel, which produces high-quality steels from recycled scrap in Europe and low-carbon bio-coal in Brazil; ...

Teva Pharmaceuticals has announced its plan to submit an MAA for Olanzapine LAI, aimed at treating adult schizophrenia, to the European Medicines Agency (EMA) in the second quarter of 2026. This ...

According to the announcement, Euronext finalized its voluntary share exchange offer submitted on July 30, 2025, to acquire all the ordinary registered shares issued by Hellenic Exchanges – Athens ...

The SPIE group lost ground this Wednesday, recording a decline of 1.52% which now positions it below its 20-day moving average, set at 48.15 euros. This correction is accompanied by a 14-day RSI ...

The DESIR program aims to develop a sovereign French capability for space radar imaging, complementing existing international agreements. Synthetic Aperture Radar (SAR) imaging will enable observation ...

The price of PROSUS stock settled at €56.62 during the last weekly session, marking a decline of 8.94% over the week. This drop places the stock below its 50-day moving average of €59.36, and slightly ...

Today's bullish movement, which slightly exceeds the support threshold of 52.72 euros, occurs in a context of high volatility. The one-month volatility index reaches 15.94, reflecting the uncertainty ...

Sanofi posted solid results for the fourth quarter and the fiscal year 2025, confirming a year of sustained revenue growth. In the fourth quarter of 2025, revenue amounted to 11,303 million euros, up ...